Quality of anticoagulation control among patients with atrial fibrillation : An experience of a tertiary care center in Saudi Arabia

BACKGROUND: Atrial fibrillation (AF) is the most common chronic rhythm disorder. Patients with AF are at an increased risk of ischemic stroke. Therefore, optimal anticoagulation is essential to reduce the risk of stroke. The aim of this study was to assess the level of anticoagulation control achiev...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Journal of the Saudi Heart Association. - 1999. - 28(2016), 4 vom: 28. Okt., Seite 239-43
1. Verfasser: Alyousif, Sarah M (VerfasserIn)
Weitere Verfasser: Alsaileek, Ahmed A
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Journal of the Saudi Heart Association
Schlagworte:Journal Article Anticoagulation Atrial fibrillation Rosendaal Time in therapeutic range Warfarin
LEADER 01000naa a22002652 4500
001 NLM264867734
003 DE-627
005 20231224211032.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jsha.2016.02.001  |2 doi 
028 5 2 |a pubmed24n0882.xml 
035 |a (DE-627)NLM264867734 
035 |a (NLM)27688671 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Alyousif, Sarah M  |e verfasserin  |4 aut 
245 1 0 |a Quality of anticoagulation control among patients with atrial fibrillation  |b An experience of a tertiary care center in Saudi Arabia 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 05.10.2016 
500 |a Date Revised 01.10.2020 
500 |a published: Print-Electronic 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a BACKGROUND: Atrial fibrillation (AF) is the most common chronic rhythm disorder. Patients with AF are at an increased risk of ischemic stroke. Therefore, optimal anticoagulation is essential to reduce the risk of stroke. The aim of this study was to assess the level of anticoagulation control achieved in patients with nonvalvular AF receiving medical care in a tertiary care hospital 
520 |a METHODS: This was a retrospective cohort study in ambulatory care clinics at tertiary care hospital in Saudi Arabia. We included 110 nonvalvular AF patients treated with warfarin for at least 3 months at King Abdulaziz Medical City, Riyadh, Saudi Arabia, between May 1, 2012, and July 31, 2012. Thereafter, international normalized ratio results were collected for 1 year. Anticoagulation control was assessed by calculating time within therapeutic range (TTR) as per the Rosendaal method 
520 |a RESULTS: The mean age was 64.9 ± 16.5 years; 60.9% were female. The mean TTR was 59%. Almost one third of the patients (32.7%) had poor anticoagulation control; TTR of <50%. Poor anticoagulation control was significantly associated with higher CHADS2 (congestive heart failure, hypertension, age, diabetes, stroke) score (p = 0.043). TTR was not significantly different between men and women. Similarly, TTR was not associated with age or duration of anticoagulation. There was no adequate information to assess the effect of other factors such as diet, compliance, and level of education on anticoagulation. Thirty-one patients (28.2%) had a history of prior stroke. The overall quality of anticoagulation was not significantly different between patients with and without stroke, (TTR was 56.3% and 60.1%, respectively; p = 0.46) 
520 |a CONCLUSION: Quality of anticoagulation in patients with AF receiving medical care in a tertiary care hospital was suboptimal, with nearly 40% of the time spent outside the therapeutic range. Methods to improve anticoagulation control among patients with AF should be implemented 
650 4 |a Journal Article 
650 4 |a Anticoagulation 
650 4 |a Atrial fibrillation 
650 4 |a Rosendaal 
650 4 |a Time in therapeutic range 
650 4 |a Warfarin 
700 1 |a Alsaileek, Ahmed A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of the Saudi Heart Association  |d 1999  |g 28(2016), 4 vom: 28. Okt., Seite 239-43  |w (DE-627)NLM098225227  |x 1016-7315  |7 nnns 
773 1 8 |g volume:28  |g year:2016  |g number:4  |g day:28  |g month:10  |g pages:239-43 
856 4 0 |u http://dx.doi.org/10.1016/j.jsha.2016.02.001  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 28  |j 2016  |e 4  |b 28  |c 10  |h 239-43